Medidata Solutions, Inc. (NASDAQ:MDSO) Analyst Ratings as of Feb 28, 2019

Medidata Solutions, Inc. (NASDAQ:MDSO) Corporate Logo
Big Money Sentiment increased to 1.39 in 2018 Q3. It has change of 0.01, from 2018Q2’s 1.38. The ratio improved due to Medidata Solutions, Inc. positioning: 11 sold and 74 reduced. 33 funds took holdings and 85 increased holdings. Investors holded 63.19 million in 2018Q2 but now own 63.90 million shares or 1.12% more.
Clearbridge Invs Ltd Limited Liability Company stated it has 0.15% in Medidata Solutions, Inc. (NASDAQ:MDSO). Schwab Charles Investment Mngmt Inc has invested 0.02% in Medidata Solutions, Inc. (NASDAQ:MDSO). Tiaa Cref Invest Mgmt Ltd Liability Company holds 0.01% in Medidata Solutions, Inc. (NASDAQ:MDSO) or 125,792 shs. Alliancebernstein L P holds 0.04% or 876,648 shs. 350,768 are owned by Morgan Stanley. Malaga Cove Cap Lc stated it has 36,593 shs. Riverhead Cap Mngmt Ltd Com reported 10,121 shs. Cim Mangement has invested 0.17% in Medidata Solutions, Inc. (NASDAQ:MDSO). 12,124 were reported by Commonwealth Of Pennsylvania Pub School Empls Retrmt System. 36,072 are held by Raymond James And Assocs. Brinker holds 0.02% or 7,736 shs. American Century Companies has 0.11% invested in Medidata Solutions, Inc. (NASDAQ:MDSO) for 1.59M shs. 3,500 are owned by S&Co Inc. California State Teachers Retirement reported 0.01% in Medidata Solutions, Inc. (NASDAQ:MDSO). Kames Public Limited Company has 31,534 shs for 0.05% of their capital.

Medidata Solutions, Inc. had 7 sales and 0 insider buys since September 4, 2018. This’s net activity of $5.30 million. $137,164 worth of Medidata Solutions, Inc. (NASDAQ:MDSO) shs were sold by TAYLOR ROBERT. Pray Michael also sold $511,140 worth of Medidata Solutions, Inc. (NASDAQ:MDSO) on Monday, November 26. On Tuesday, October 23 Otner Michael I. had sold 7,030 shs worth $487,881.

Medidata Solutions, Inc. (NASDAQ:MDSO) Ratings Coverage

A total of 2 analysts rate Medidata Solutions (NASDAQ:MDSO) as follows: 0 “Buy”, 1 “Hold” and 1 “Sell”. Тherefore 0 are bullish. (NASDAQ:MDSO) has 2 ratings reports on Feb 28, 2019 according to StockzIntelligence. On Thursday, December 13 the stock has “Underweight” rating by JP Morgan. Listed here are Medidata Solutions, Inc. (NASDAQ:MDSO) PTs and latest ratings.

02/01/2019 Broker: Leerink Swann Rating: Market Perform Initiates Coverage On
13/12/2018 Broker: JP Morgan Old Rating: Neutral New Rating: Underweight Downgrade

MDSO is reaching $74.79 during the last trading session, after decreased 0.28%.Currently Medidata Solutions, Inc. is uptrending after 9.82% change in last February 28, 2018. MDSO has also 151,892 shares volume. MDSO outperformed the S&P500 by 9.82%.

Medidata Solutions, Inc. provides cloud solutions for life sciences worldwide.The company has $4.59 billion market cap. It offers Medidata Clinical Cloud that provides a software-as-a-service platform of technology and data analytics solutions to optimize activities across clinical development.The P/E ratio is 87.99. The companyÂ’s platform solutions includes Plan Study that addresses the areas to ensure optimal study design, grant development and negotiation, and investigator payments; and Support Sites, which provides robust risk management, reduced source document verification, real-time monitoring, on-time, accurate payments.

For more Medidata Solutions, Inc. (NASDAQ:MDSO) news brought out briefly go to: Bizjournals.com, Nasdaq.com, Nasdaq.com, Nasdaq.com or Nasdaq.com. The titles are as follows: “Medidata Solutions quadrupling local presence, could hire hundreds – Boston Business Journal” brought out on February 13, 2019, “Can Canadian Market Drive Canopy Growth (CGC) Q3 Earnings? – Nasdaq” on February 11, 2019, “Medidata Solutions (MDSO) Expected to Beat Earnings Estimates: Can the Stock Move Higher? – Nasdaq” with a publish date: February 05, 2019, “Medidata Solutions Becomes Oversold (MDSO) – Nasdaq” and the last “Stocks Take a Small Step Back – Nasdaq” with publication date: February 07, 2019.

Medidata Solutions, Inc. (NASDAQ:MDSO) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.